Cited by 23Endometriosis Research and TreatmentGynecological conditions and treatmentsEndometrial and Cervical Cancer Treatments

PAX8: A Highly Sensitive Marker for the Glands in Extragenital Endometriosis

Arakawa, Tomoko, Fukuda, Shinya, Hirata, Tetsuya, Neriishi, Kazuaki, Wang, Yu, Takeuchi, Arisa, Saeki, Ai, Harada, Miyuki +7 more·2020·Reproductive Sciences

Abstract

In cases of extragenital endometriosis or microscopic endometriosis lesions, pathological diagnosis can be challenging because endometriotic stroma and glands represent only a minor component of fibrotic endometriotic lesions. For better accuracy of diagnosis, the development of a sensitive and specific epithelial marker is beneficial. Previous studies showed that PAX8 is a highly sensitive and specific marker for primary and metastatic Mullerian epithelial tumors. Therefore, we sought to examine whether PAX8 is a highly sensitive marker for glands in extragenital endometriosis. Eight and 47 samples of ovarian endometrioma and extragenital endometriosis, respectively, were evaluated in this study. We calculated the percentage of samples positively immunostained for PAX8, CD10, estrogen receptor (ER), and progesterone receptor (PR). PAX8 was positive for endometriotic epithelial cells in 95.7% (45/47) of extragenital endometrioses and in 100% (8/8) of ovarian endometrioses. CD10 was positive for endometriotic stromal cells in 97.9% (46/47) of extragenital endometrioses. PAX8 was strongly positive for glands, even in a CD10-negative case. The expression of PAX8, CD10, and PR was not affected by preoperative hormonal therapy, and the positive rate of ER staining was significantly reduced by preoperative hormonal therapy. In conclusion, PAX8 is a highly sensitive epithelial marker for extragenital endometriosis. This specific expression was maintained under hormonal therapy. It is noteworthy that extragenital endometriosis maintains the expression of this lineage marker, although it occurs at various sites, and its cause and mechanism of development might be different. PAX8 nuclear expression can be useful in detecting extragenital endometriosis in clinical practice.

Integrity signals

Registry

Crossref · 10.1007/s43032-020-00186-7

Cites

23 of 23 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The authors' group reported the usefulness of PAX8 as an endometriotic epithelial marker in the diagnosis of extragenital endometriosis, including thoracic endometriosis.

    “Recently, our group reported the usefulness of PAX8 as an endometriotic epithelial marker in the diagnosis of extragenital endometriosis, including thoracic endometriosis.”

    From Extra-pelvic endometriosis: a review. (2020) · cites this paper as [93]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Arakawa, T., Fukuda, S., Hirata, T., Neriishi, K., Wang, Y., Takeuchi, A., Saeki, A., Harada, M., Hirota, Y., Matsumoto, T., Koga, K., Wada-Hiraike, O., Kurihara, M., Fujii, T., & Osuga, Y.
Affiliations
  • The University of Tokyo (JP)
  • Osaka Hospital (JP)
  • Nissan Tamagawa Hospital (JP)
Corresponding author
Hirata, Tetsuya
Venue
Reproductive Sciences
Published
2020-05-19
Volume
27
Issue
8
Pages
1580-1586
ISSN
  • 1933-7191 (ISSN-L)
  • 1933-7205
OpenAlex
W4244299832
Cited by
23
References
23
Citations by year
2026: 5 · 2025: 2 · 2024: 6 · 2023: 4 · 2022: 3 · 2021: 1 · 2020: 2
FWCI
2.21
Type
journal article
Language
en
Open access
closed
Locations
Reproductive Sciences (publishedVersion)
Funders
Japan Society for the Promotion of Science (19H03144, 18K09221)
Topics
  • Health Sciences › Medicine › Reproductive Medicine › Endometriosis Research and Treatment
  • Health Sciences › Medicine › Obstetrics and Gynecology › Gynecological conditions and treatments
  • Health Sciences › Medicine › Obstetrics and Gynecology › Endometrial and Cervical Cancer Treatments
Keywords
PAX8, extragenital endometriosis, endometrioma, CD10, estrogen receptor, progesterone receptor, immunohistochemical markers, preoperative hormonal therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review